Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: Implications for the treatment of CNS disorders

Molecular Psychiatry

Volumn 1, Issue 4, 1996, Pages 265-277

  Behan, D P ^a   Grigoriadis, D E ^a   Lovenberg, T ^a   Chalmers, D ^a   Heinrichs, S ^a   Liaw, C ^a   De Souza, E B ^a  

^a NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

Alzheimer's disease; Anxiety; Binding protein; Corticotropin releasing factor (CRF); Depression; Receptors; Stress

Indexed keywords

CARRIER PROTEIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR-BINDING PROTEIN;

ANIMAL; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; GENETICS; HUMAN; MOLECULAR GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SEQUENCE HOMOLOGY;

ANIMALS; CARRIER PROTEINS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; CORTICOTROPIN-RELEASING HORMONE; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0030229898     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (113)

1. Harris GW. Functional grafts of the anterior pituitary gland. Proc Royal Soc 1952; 139: 263-267.
2. Guillemin R, Rosenberg B. Humoral hypothalamic control of anterior pituitary: a study with combined tissue cultures. Endocrinology 1955; 57: 599-607.
3. Saffran M, Serially AV, Benfey BG. Stimulation of the release of cortiocotrophin from the adenohypophysis by a neurohypophysial factor. Endocrinology 1955; 57: 439-444.
4. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic: peptide that stimulates secretion of corticotropin and β-endorphin. Science 1981; 213: 1394-1397.
5. Shibahara S, Morimoto Y, Furatani Y, Notake M, Takahashi H, Shimizu S, Horikawa S, Numa S. Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene. EMBO J 1983; 2: 775-779.
6. Rivier J, Spiess J, Vale W. Characterization of rat hypothalamic corticotropin-releasing factor. Proc Natl Acad Sci USA 1983; 80: 4851-4855.
7. Knob GF. Stress, corticotropin-releasing factor and behavior. Perspect Behav Med 1985; 2: 39-52.
8. Koob GF, Bloom FE. Corticotropin-releasing factor and behavior. Fed Proc 1905; 44: 259-263.
9. Diamant M, De Wied D. Structure-related effects of CRF and CRF-derived peptides:dissociation of behavioral, endocrine and autonomic activity. Neuroendocrinology 1993; 57: 1071-1081.
10. Richard D. Involvement of corticotropin-releasing factor in the control of food intake and energy expenditure. Ann New York Acad Sci 1993; 697: 155-172.
11. Rothwell NJ. Central effects of CRF on metabolism and energy balance. Neurosci Behav Rev 1990; 14: 263-271.
12. Fisher LA, Rivier J, Rivier C, Speiss J, Vale WW, Brown MR. Corticotropin-releasing factor (CRF). Central effects on mean arterial pressure and heart rate in rats. Endocrinology 1982; 110: 2222-2224.
13. Lenz HJ, Fisher LA, Vale WW, Brown MR. Corticotropin-releasing factor, sauvagine and urotensin I: effects on blood flow. Am J Physiol 1985; 249: R85-R90.
14. Kiang JG, Wei ET. Corticotropin-releasing factor inhibits thermal injury. J Pharmacol Exp Therapeut 1987; 243: 517-520.
15. Crofford LJ, Sano H, Karalis K, Webster EL, Goldmuntz EA, Chrousos GP, Wilder RL. Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. J Clin Invest 1992; 90(6): 2555-2564.
16. Crofford LJ, Sano H, Karalis K, Friedman TC, Epps HR, Remmers EF, Mathern P, Chrousos GP, Wilder RL. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. J Immunol 1993; 151: 1587-1596.
17. Letter A, McMaster B, Moore G, Schlefinger D. Complete amino acid sequence of urotensin I, a hypotensive and corticotropin releasing neuropeptide from Catoftomus. Science 1982; 218: 162-164.
18. Montecucchi PC, Henschen A. Amino acid composition and sequence analysis of sauvagine, a new active peptide from the skin of phyomedusa sauvagei. J Prot Res 1981; 18: 113-120.
19. Rivier C, Rivier J, Lederis K, Vale W. In vitro and in vivo ACTH-releasing activity of ovine CRF, sauvagine and urotensin 1. Regul Peptides 1983; 5: 139-143.
20. Britton DR, Hoffman DK, Lederis K, Rivier J. A comparison of the behavioral effects of CRF, sauvagine and urotensin I. Brain Res 1984; 304: 201-205.
21. Morley SD, Schonrock C, Richter D, Okawara Y, Lederis K. Corticotropin-releasing factor (CRF) gene family in the brain of the teleost fish Castostomus commersoni (white sucker): molecular analysis predicts precursors for two CRFs and one urotensin I peptide. Mol Marine Biol Biotechnol 1991; 1: 48-57.
22. Stenzel-Poore MP, Heldwein KA, Stenzel P, Lee S, Vale WW. Characterization of the genomic corticotropin-releasing factor (CRF) gene from Xenopus laevis: two members of the CRF family exist in amphibians. Mol Endocrinol 1992; 6: 1716-1724.
23. Vaughan J, Donaldson C, Bittencourt J, Perrin M, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE, Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995; 378: 287-291.
24. De Souza EB, Nemeroff CB (eds). Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide. CRC Press: Boca Raton, Florida, 1990, 365 pp.
25. De Souza EB. CRH defects in Alzheimer's and other neurologic diseases. Hosp Pract 1988; 23: 59-71.
26. De Souza EB. Role of corticotropin-releasing factor in neuropsychiatric disorders and neurodegenerative diseases. In: Seamon KB (ed). Annual Reports in Medicinal Chemistry. Academic: Press: San Diego, 1990, pp 215-2Z4.
27. Sasaki A, Shinkawa O, Margioris AN, Liotta A, Sato S, Murakami O, Meigan G, Shimuzu Y, Hanew K, Yoshinaga K. Immuoreactive CRF in human plasma during pregnancy, labor and delivery. J Clin Endocrinol Metab 1987; 64: 224-229.
28. Campbell EA, Linton EA, Wolfe CDA, Scraggs PR, Jones MT, Lowry PJ. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab 1987; 64: 1054-1059.
29. Behan DP, Linton EA, Lowry PJ. Isolation of the human plasma corticotrophin-releasing factor-binding protein. J Endocrinology 1989; 122: 23-31.
30. Potter E, Behan DP, Fischer WH, Linton EA, Lowry PJ, Vale WW. Cloning and characterization of the cDNAs for human and rat corticotropin-releasing factor-binding proteins. Nature 1991; 349 (6308): 423-426.
31. Cortright DN, Nicoletti A, Seasholtz AF. Molecular and biochemical characterization of the mouse brain corticotropin-releasing hormone-binding protein. Mol Cell Endocrinol 1995; 111: 147-157.
32. Behan DP, Cepoi D, Fisher WH, Park M, Lowry PJ, Sutton S, Vale WW. Characterization of a sheep brain corticotropin releasing factor binding protein. Brain Res 1996; 709: 265-274.
33. Fischer HW, Behan DP, Park M, Potter E, Lowry PJ, Vale W. Assignment of disulfide bonds in corticotropin releasing factor-binding protein. J Biol Chem 1994; 269: 4313-4316.
34. Barclay NA, Johnson P, McCaughan GW, Williams AF. Immunoglobulin-related structures associated with vertebrate cell surfaces. In: Tak W Mak (ed). In the T-cell Receptors. Plenary Press: New York, 1988, pp 53-58.
35. Sutton SW, Behan DP, Lahrichi SL, Kaiser R, Corrigan A, Lowry P, Potter E, Perrin MH, Rivier J, Vale W. Ligand requirements of the human corticotropin releasing factor-binding protein. Endocrinology 1995; 136: 1097-1102.
36. Behan DP, Potter E, Lewis KA, Jenkins NA, Copeland N, Lowry PJ, Vale W. Cloning and structure of the human corticotrophin releasing factor-binding protein gene (CRHBP). Genomics 1993; 16: 63-68.
37. Chen R, Lewis KA, Perrin MH, Vale WW. Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 1993; 90 (19): 8967-8971.
38. Chang CP, Pearse RI, O'Connell S, Rosenfeld MG. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 1993; 11 (6): 1187-1195.
39. Perrin MH, Donaldson CJ, Chen R, Lewis KA, Vale WW. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 1993; 133 (6): 3058-3061.
40. Vita N, Laurent P, Lefort S, Chalon P, Lelias JM, Kaghad M, Le FG, Caput D, Ferrara P. Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett 1993; 335 (1): 1-5.
41. Grigoriadis DE, De Souza EB. Heterogeneity between brain and pituitary corticotropin-releasing factor receptors is due to differential glycosylation. Endocrinology 1989; 125 (4): 1877-1888.
42. De Souza EB, Insel TR, Perrin MH, Rivier J, Vale WW, Kuhar MJ. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J Neurosci 1985; 5: 3189-3203.
43. Grigoriadis DE, Liaw CW, Oltersdorf T, De Souza EB. Characterization of stable expression of cloned corticotropin-releasing factor receptors. Soc Neurosci Abs 1994; 20: 1345.
44. De Souza EB. Corticotropin-releasing factor receptors in the rat central nervous system: characterization and regional distribution. J Neurosci 1987; 7: 88-100.
45. De Souza EB. Corticotropin-releasing hormone receptors. In: Bjorklund A, Hokfelt T, Kuhar MJ (eds). Handbook of Chemical Neuroanatomy - Neuropeptide Receptors in the CNS, Part III. Elsevier: Amsterdam, 1992, pp 145-185.
46. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB, Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 1995; 92: 836-840.
47. 2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 1995; 136: 4139-4142.
48. 2 receptor gene and cDNA. Endocrinology 1996; 137 (1): 72-77.
49. Kishimoto T, Pearse II RV, Lin CR, Rosenfeld MG. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 1995; 92: 1108-1112.
50. Perrin M, Donaldson C, Chen R, Blount A, Berggren T, Bilezikjian L, Sawchenko P, Vale W. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 1995; 92: 2969-2973.
51. Potter E, Behan DP, Linton EA, Lowry PJ, Sawchenko PE, Vale WW. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci USA 1992; 89: 4192-4196.
52. Potter E, Behan D, Lowry P, Vale W. HPA axis can alter expression of corticotropin-releasing factor binding protein in the pituitary. 75th Annual Meeting of the Endocrine Society, Las Vegas, 1993, Abstract 1675.
53. Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, Sawchenko PE, Vale W. Distribution of corticotropin-releasing factor receptor expression in the rat brain and pituitary. Proc Natl Acad Sci 1994; 91: 8777-8781.
54. 1 receptor mRNA expression. J Neurosci 1995; 15: 6340-6350.
55. De France JF (ed). The Septal Nuclei. Plenum: New York, 1976.
56. Owens MJ, Nemeroff CB. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 1991; 43 (4): 425-473.
57. Nemeroff CB, Widerlov E, Bissett G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale WW. Elevated concentration of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984; 226: 1342-1344.
58. Roy A, Pickar D, Paul S, Doran A, Chrousos GP, Gold PW. CSF corticotropin releasing hormone in depressed patients and normal control subjects. Am J Psychiatry 1987; 143: 896-899.
59. Nemeroff CB, Owens MJ, Bissett G, Andorn AC, Stanley M. Reduced corticotropin-releasing factor receptor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 1988; 45: 577-579.
60. Nemeroff CB, Bissette G, Akil H, Fink M. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy: corticotropin-releasing factor, β-endorphin and somatostatin. Br J Psychiatry 1991; 158: 59-63.
61. Gold PW, Chrousos G, Kellner C et al. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am J Psychiatry 1984; 141: 619-627.
62. Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W, Avgerinos P, Paul S, Oldfield EH, Cutler GBJ, Chrousos GP. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. New Engl J Med 1986; 314: 1329-1334.
63. Koob GF, Heinrichs SC, Pich EM, Menzaghi F, Baldwin H, Miczek K, Britton KT. The role of corticotropin-releasing factor in behavioral responses to stress. In: Chadwick DJ, Marsh J, Ackrill K (eds). CIBA Foundation Symposium on Corticotropin-Releasing Factor. J. Wiley and Sons: Chichester, 1993, pp 277-295. (Symposium CF, ed vol 172).
64. Roy-Byrne PP, Uhde T, Post R, Gallucci W, Chrousos GP, Gold PW. The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry 1986; 143: 896-899.
65. Morley JE, Levine AS. Corticotropin-releasing factor and ingestive behaviors. In: De Souza EB, Nemeroff CB (eds). Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide. CRC Press: Boca Raton, 1990, pp 267-274.
66. Rivier C, Vale W. Effect of long term administration of CRF on the pituitary adrenal and pituitary-gonadal axis in the male rat. J Clin Invest 1984; 75: 689-694.
67. Lyons MK, Anderson RE, Meyer FB. Corticotropin releasing factor antagonist reduces ischemic hippocampal neuronal injury. Brain Res 1991; 545: 339-342.
68. Strijbos PJLM, Relton JK, Rothwell NJ. Corticotrophin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischaemia or activation of NMDA receptors in the rat brain. Brain Res 1994; 656: 405-408.
69. Bernardini GL, Richards DB, Lipton JM. Antipyretic effect of centrally administered CRF. Peptides 1984; 5: 57-59.
70. Butcher SP, Bullock R, Graham DI, McCulloch J. Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke 1990; 21: 1727-1733.
71. Nicholls D, Attwell D. The release and uptake of excitory amino acids. Trends Pharmacol Sci 1990; 11: 462-468.
72. Choi DW. Methods for antagonising glutamate neurotoxicity. Brain Metab Rev 1990; 2: 105-147.
73. McCulloch JBR, Teasdale GM. Excitatory amino acid antagonists: opportunities for the treatment of ischaemic brain damage in man. In: BS Meldrum (ed). Excitatory Amino Acid Antagonists. Blackwell: 1991, pp 287-325.
74. Bissette G, Reynolds GP, Kilts CD, Widerlov W, Nemeroff CB. Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. J Am Med Assoc 1985; 254: 3067-3069.
75. De Souza EB, Whitehouse PJ, Kuhar MJ, Price DL, Vale WW. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease. Nature 1986; 319: 593-595.
76. De Souza EB, Whitehouse PJ, Price DL, Vale WW. Abnormalities in corticotropin-releasing hormone (CRH) in Alzheimer's disease and other human disorders. Ann New York Acad Sci 1987; 512: 237-247.
77. Whitehouse PJ, Vale WW, Zweig RM, Singer HS, Mayeux R, Price DL, De Souza EB. Reduction in corticotropin-releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy. Neurology 1987; 37: 905-909.
78. Behan DP, Heinrichs SC, Troncoso JC, Liu XJ, Kawas CH, Ling N, De Souza EB. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature 1995; 378: 284-287.
79. Grigoriadis DE, Struble RG, Price DL, De Souza EB. Normal pattern of labeling of cerebral cortical corticotropin-releasing factor (CRF) receptors in Alzheimer's disease: evidence from chemical cross-linking studies. Neuropharmacology 1989; 28 (7): 761-764.
80. Deleted in proof.
81. Mouradian MM, Farah JM Jr, Mohr E, Fabbrini G, O'Donohue TL, Chase TN. Spinal fluid CRF reduction in Alzheimer's disease. Neuropeptides 1986; 8: 393-400.
82. May C, Rapoport SI, Tomai TP, Chrousos GP, Gold PW. Cerebral spinal fluid concentrations of corticotropin-releasing hormone (CRH) and corticotropin (ACTH) are reduced in Alzheimer's disease. Neurology 1987; 37: 535-538.
83. Pomara N, Singh RR, Deptula D, Lewitt PA, Bissett G, Stanley M, Nemeroff CB. CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: its relationship to severity of dementia and monoamine metabolites. Biol Psychiatry 1989; 26: 500-504.
84. Powers RE, Walker LC, De Souza EB, Vale WW, Struble RG, Whitehouse PJ, Price DL. Immunohistochemical study of neurons containing corticotropin-releasing factor in Alzheimer's disease. Synapse 1987; 1: 405-410.
85. Lesch KP, Ihl R, Frohlich L, Rupprecht R, Muller U, Schulte HM, Maurer K. Endocrine responses to growth hormone releasing hormone and corticotropin releasing hormone in early-onset Alzheimer's disease. Psychiatry Res 1990; 33: 107-112.
86. Dodt C, Dittmann J, Hruby J, Spath-Schwalbe E, Born J, Schuttler R, Fehm HL. Different regulation of adrenocorticotropin and cortisol secretion in young, mentally healthy elderly and patients with senile dementia of Alzhei-mer's type. J Clin Endocrinol Metab 1991; 72: 272-276.
87. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. JAMA 1992; 267: 1244-1252.
88. Krahn DD, Gosnell BA, Grace M, Levine AS. CRF antagonist partially reverses CRF- and stress-induced effects on feeding. Brain Res Bull 1986; 17: 285-289.
89. Heinrichs SC, Koob GF. Corticotropin-releasing factor modulates dietary preference in nutritionally and physically stressed rats. Psychopharmacology 1992; 109: 177-184.
90. Appel NM, Owens MJ, Culp S, Zazcek R, Contrera JE, Bissette G, Nemeroff CB, De Souza EB. Role for brain corticotropin-releasing factor in the weight-reducing effects of chronic fenfluramine treatment in rats. Endocrinology 1991; 128: 3237-3246.
91. Krahn DD, Gosnell BA. Corticotropin-releasing hormone: possible role in eating disorders. Psychiat Med 1989; 7: 235-244.
92. McCarthy DH, McKibbin PE, Perkins AV, Linton EA, Williams G. Alterations in hypothalamic NPY and CRF in anorexic tumor-bearing rats. Am J Physiology 1993; 264: E638-E643.
93. Menzaghi F, Heinrichs SC, Merlo Pick E, Tilders FJH, Koob GF. Involvement of hypothalamic corticotropin-releasing factor neurons in behavioral responses to novelty in rats. Neurosci Lett 1994; 168: 139-142.
94. Brown MR, Fisher LA. Regulation of the autonomic nervous system by corticotropin-releasing factor. In: De Souza EB, Nemeroff CB (eds). Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide. CRC Press: Boca Raton, FL, 1990, pp 291-298.
95. Conte-Devolx B, Grino M, Nieoullon A, Javoy-Agid F, Castanas E, Guillaume V, Tonon MC, Vaudry H, Oliver G. Corticoliberin, somatocrinin and amine contents in normal and parkinsonian human hypothalamus. Neurosci Lett 1985; 56 (2): 217-222.
96. Calogero AE, Sternberg EM, Bagdy G, Smith C, Bernardini R, Aksentijevich S, Wilder RL, Gold PW, Chrousos GP. Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting a global defect in CRH secretion. Neuroendocrinology 1992; 55: 600-608.
97. Owens MJ, Bissette G, Nemeroff CB. Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain. Synapse 1989; 4: 196-202.
98. Britton K, Morgan J, Rivier J, Vale W, Koob GF. Chlordiazepoxide attenuates CRF-induced response suppression in the conflict test. Psychopharmacology 1985; 86: 170-174.
99. Britton KT, Lee G, Koob GF. Corticotropin-releasing factor and amphetamine exaggerate partial agonist properties of benzodiazepine agonist Ro 15-1788 in the conflict test. Psychopharmacology 1988; 94: 306-311.
100. Swerdlow NR, Geyer MA, Vale WW, Koob GF. Corticotropin releasing factor potentiates acoustic startle in rats: blockade in chlordiazepoxide. Psychopharmacology 1986; 88: 142-152.
101. Lazosky AJ, Britton DL. Effects of 5-HT-1A receptor agonists on CRF-induced behavior. Psychopharmacology 1991; 104: 132-136.
102. Matinez JA, Bueno L. Buspirone inhibits corticotropin-releasing factor and stress-induced cecal motor response in rats by acting through 5-HT1A receptors. Eur J Pharmacol 1991; 202: 379-383.
103. Reul J, Labeur M, Grigoriadis D, De Souza EB, Holsber F. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology 1994; 60: 509.
104. Reul JMHM, Stec I, Soder M, Holsboer F. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary adrenocortical system. Endocrinology 1993; 133: 312.
105. Aldirich PE, Arvantis AG, Cheeseman RS, Chorvat RJ, Christos TE, Gilligan PJ, Grigoriadis DE, Hodge CN, Krenitsky PJ, Schofield EL, Wasserman ZR. 1995; World Patent Application WO 95/10506.
106. Chen YL. 1994; World Patent Application WO 94/13677.
107. Bright GM, Welch JWM. 1994; World Patent Application WO 94/13661.
108. Bright GM. 1994; World Patent Application WO 94/13644.
109. Faraci WS, Welch JWM. 1994: World Patent Application WO 94/13643.
110. Hoffman BJ, Mezey E, Brownstein MJ. Cloning of a serotonin transporter affected by antidepressants. Science 1991; 254: 579-580.
111. Pacholozyk T, Blakely RD, Amara SG. Expression cloning of a cocaine-antidepressant sensitive human noradrenaline transporter. Nature 1991; 350: 350-353.
112. Guastella J, Nelson N, Nelson H, Czyzyk L, Keynan S, Miedel MC, Davidson N, Lester HA, Kunner BI. Cloning and expression of a rat brain GABA transporter. Science 1990; 249: 1303-1306.
113. Paxinos G, Watson C (eds). The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press: Orlando, 1986.